메뉴 건너뛰기




Volumn 13, Issue 6, 2015, Pages 643-651

Management and prognosis of atrial fibrillation in the diabetic patient

Author keywords

ablation; atrial fibrillation; bleeding; cardioversion; diabetes mellitus; HbA1c; heart failure; novel oral anticoagulants; stroke

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCYSTEINE; ANTIVITAMIN K; APIXABAN; ASCORBIC ACID; BLOOD CLOTTING FACTOR 10A INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; POLYUNSATURATED FATTY ACID; RIVAROXABAN; WARFARIN; XANTHINE OXIDASE INHIBITOR; ANTICOAGULANT AGENT;

EID: 84929899537     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.2015.1043892     Document Type: Review
Times cited : (16)

References (94)
  • 1
    • 0020074665 scopus 로고
    • Epidemiologic features of chronic atrial fibrillation: The Framingham study
    • Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306(17):1018-22
    • (1982) N Engl J Med , vol.306 , Issue.17 , pp. 1018-1022
    • Kannel, W.B.1    Abbott, R.D.2    Savage, D.D.3
  • 2
    • 1542577591 scopus 로고    scopus 로고
    • Rising rates of hospital admissions for atrial fibrillation
    • Friberg J, Buch P, Scharling H, et al. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 2003;14(6): 666-72
    • (2003) Epidemiology , vol.14 , Issue.6 , pp. 666-672
    • Friberg, J.1    Buch, P.2    Scharling, H.3
  • 3
    • 0028299731 scopus 로고
    • Independent risk factors for atrial fibrillation in a population-based cohort: The Framingham Heart study
    • Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart study. JAMA 1994; 271(11):840-4
    • (1994) JAMA , vol.271 , Issue.11 , pp. 840-844
    • Benjamin, E.J.1    Levy, D.2    Vaziri, S.M.3
  • 5
    • 84922446493 scopus 로고    scopus 로고
    • Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013
    • Olesen JB, Srensen R, Hansen ML, et al. Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. Europace 2015;17(2):187-93
    • (2015) Europace , vol.17 , Issue.2 , pp. 187-193
    • Olesen, J.B.1    Srensen, R.2    Hansen, M.L.3
  • 6
    • 70450003685 scopus 로고    scopus 로고
    • Trends in catheter ablation for atrial fibrillation in the United States
    • Kneeland PP, Fang MC. Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med 2009;4(7):E1-5
    • (2009) J Hosp Med , vol.4 , Issue.7 , pp. E1-5
    • Kneeland, P.P.1    Fang, M.C.2
  • 7
    • 41949131420 scopus 로고    scopus 로고
    • Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial)
    • Aksnes TA, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial). Am J Cardiol 2008; 101(5):634-8
    • (2008) Am J Cardiol , vol.101 , Issue.5 , pp. 634-638
    • Aksnes, T.A.1    Schmieder, R.E.2    Kjeldsen, S.E.3
  • 8
    • 40549117855 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of development of atrial fibrillation the niigata preventive medicine study
    • Watanabe H, Tanabe N, Watanabe T, et al. Metabolic Syndrome and Risk of Development of Atrial Fibrillation The Niigata Preventive Medicine Study. Circulation 2008;117(10):1255-60
    • (2008) Circulation , vol.117 , Issue.10 , pp. 1255-1260
    • Watanabe, H.1    Tanabe, N.2    Watanabe, T.3
  • 9
    • 70349675746 scopus 로고    scopus 로고
    • Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation
    • Nichols GA, Reinier K, Chugh SS. Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care 2009;32(10): 1851-6
    • (2009) Diabetes Care , vol.32 , Issue.10 , pp. 1851-1856
    • Nichols, G.A.1    Reinier, K.2    Chugh, S.S.3
  • 10
    • 77954424113 scopus 로고    scopus 로고
    • Diabetes mellitus, glycemic control, and risk of atrial fibrillation
    • Dublin S, Glazer N, Smith N, et al. Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation. J Gen Intern Med 2010;25(8):853-8
    • (2010) J Gen Intern Med , vol.25 , Issue.8 , pp. 853-858
    • Dublin, S.1    Glazer, N.2    Smith, N.3
  • 11
    • 79958814579 scopus 로고    scopus 로고
    • Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
    • Huxley RR, Filion KB, Konety S, et al. Meta-Analysis of Cohort and Case-Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation. Am J Cardiol 2011;108(1):56-62
    • Am J Cardiol 2011 , vol.108 , Issue.1 , pp. 56-62
    • Huxley, R.R.1    Filion, K.B.2    Konety, S.3
  • 12
    • 27744526856 scopus 로고    scopus 로고
    • Diabetes mellitus and atrial fibrillation: Perspectives on epidemiological and pathophysiological links
    • Lip GYH, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links. Int J Cardiol 2005;105(3):319-21
    • (2005) Int J Cardiol , vol.105 , Issue.3 , pp. 319-321
    • Gyh, L.1    Varughese, G.I.2
  • 13
    • 53949123542 scopus 로고    scopus 로고
    • Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects
    • Johansen OE, Brustad E, Enger S, et al. Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects. Cardiovasc Diabetol 2008;7:28
    • (2008) Cardiovasc Diabetol , vol.7 , pp. 28
    • Johansen, O.E.1    Brustad, E.2    Enger, S.3
  • 14
    • 40149100969 scopus 로고    scopus 로고
    • Atrial fibrillation and antithrombotic therapy in a 75-year-old population
    • Tveit A, Abdelnoor M, Enger S, et al. Atrial fibrillation and antithrombotic therapy in a 75-year-old population. Cardiology 2008; 109(4):258-62
    • (2008) Cardiology , vol.109 , Issue.4 , pp. 258-262
    • Tveit, A.1    Abdelnoor, M.2    Enger, S.3
  • 15
    • 0029029056 scopus 로고
    • The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study
    • Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. Am J Med 1995; 98(5):476-84
    • (1995) Am J Med , vol.98 , Issue.5 , pp. 476-484
    • Krahn, A.D.1    Manfreda, J.2    Tate, R.B.3
  • 16
    • 4444364450 scopus 로고    scopus 로고
    • Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community
    • O stgren CJ, Merlo J, Rastam L, et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004;6(5):367-74
    • (2004) Diabetes Obes Metab , vol.6 , Issue.5 , pp. 367-374
    • Ostgren, C.J.1    Merlo, J.2    Rastam, L.3
  • 17
    • 0036128687 scopus 로고    scopus 로고
    • Incidence of chronic atrial fibrillation in general practice and its treatment pattern
    • Ruigomez A, Johansson S, Wallander M-A, et al. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J Clin Epidemiol 2002;55(4):358-63
    • (2002) J Clin Epidemiol , vol.55 , Issue.4 , pp. 358-363
    • Ruigomez, A.1    Johansson, S.2    Wallander, M.-A.3
  • 18
    • 0034771626 scopus 로고    scopus 로고
    • Hospitalizations for atrial fibrillation in the general male population: Morbidity and risk factors
    • Wilhelmsen L, Rosengren A, Lappas G. Hospitalizations for atrial fibrillation in the general male population: morbidity and risk factors. J Intern Med 2002;250(5):382-9
    • (2002) J Intern Med , vol.250 , Issue.5 , pp. 382-389
    • Wilhelmsen, L.1    Rosengren, A.2    Lappas, G.3
  • 19
    • 14844286948 scopus 로고    scopus 로고
    • Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years
    • Jeong JH. Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci 2005;20(1): 26-30
    • (2005) J Korean Med Sci , vol.20 , Issue.1 , pp. 26-30
    • Jeong, J.H.1
  • 20
    • 77950803611 scopus 로고    scopus 로고
    • Atrial fibrillation in the Malmo diet and cancer study: A study of occurrence, risk factors and diagnostic validity
    • Smith J, Platonov P, Hedblad B, et al. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25(2):95-102
    • Eur J Epidemiol 2010 , vol.25 , Issue.2 , pp. 95-102
    • Smith, J.1    Platonov, P.2    Hedblad, B.3
  • 21
    • 56649106325 scopus 로고    scopus 로고
    • An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China
    • Zhou Z, Hu D. An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol 2008;18(5):209-16
    • (2008) J Epidemiol , vol.18 , Issue.5 , pp. 209-216
    • Zhou, Z.1    Hu, D.2
  • 22
    • 18144363654 scopus 로고    scopus 로고
    • Overweight and obesity as risk factors for atrial fibrillation or flutter: The danish diet, cancer, and health study
    • Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study. Am J Med 2005;118(5):489-95
    • (2005) Am J Med , vol.118 , Issue.5 , pp. 489-495
    • Frost, L.1    Hune, L.J.2    Vestergaard, P.3
  • 23
    • 0346995016 scopus 로고    scopus 로고
    • Inflammation as a risk factor for atrial fibrillation
    • Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a Risk Factor for Atrial Fibrillation. Circulation 2003;108(24): 3006-10
    • (2003) Circulation , vol.108 , Issue.24 , pp. 3006-3010
    • Aviles, R.J.1    Martin, D.O.2    Apperson-Hansen, C.3
  • 24
    • 84856153956 scopus 로고    scopus 로고
    • Psoriasis and risk of atrial fibrillation and ischaemic stroke: A danish nationwide cohort study
    • [[Cited 16 May 2012]
    • Ahlehoff O, Gislason GH, Jrgensen CH, et al. Psoriasis and risk of atrial fibrillation and Ischaemic stroke: a Danish Nationwide Cohort study. Eur Heart J [Internet] 2011; Available from: http://eurheartj. oxfordjournals.org/content/early/2011/08/25/eurheartj.ehr285 [[Cited 16 May 2012]
    • (2011) Eur Heart J [Internet]
    • Ahlehoff, O.1    Gislason, G.H.2    Jrgensen, C.H.3
  • 25
    • 84893044642 scopus 로고    scopus 로고
    • Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: A nationwide study
    • Kristensen SL, Lindhardsen J, Ahlehoff O, et al. Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study. Europace 2014;16(4):477-84
    • (2014) Europace , vol.16 , Issue.4 , pp. 477-484
    • Kristensen, S.L.1    Lindhardsen, J.2    Ahlehoff, O.3
  • 26
    • 0035846667 scopus 로고    scopus 로고
    • C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation
    • Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001;104(24):2886-91
    • (2001) Circulation , vol.104 , Issue.24 , pp. 2886-2891
    • Chung, M.K.1    Martin, D.O.2    Sprecher, D.3
  • 27
    • 26044478131 scopus 로고    scopus 로고
    • Inflammation in the genesis and perpetuation of atrial fibrillation
    • Engelmann MDM, Svendsen JH. Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 2005;26(20):2083-92
    • (2005) Eur Heart J , vol.26 , Issue.20 , pp. 2083-2092
    • Mdm, E.1    Svendsen, J.H.2
  • 28
    • 80054102752 scopus 로고    scopus 로고
    • Coronary microvascular dysfunction in diabetes mellitus: A review
    • Picchi A, Capobianco S, Qiu T, et al. Coronary microvascular dysfunction in diabetes mellitus: a review. World J Cardiol 2010;2(11):377-90
    • (2010) World J Cardiol , vol.2 , Issue.11 , pp. 377-390
    • Picchi, A.1    Capobianco, S.2    Qiu, T.3
  • 29
    • 84908396474 scopus 로고    scopus 로고
    • Diabetes mellitus and atrial remodeling: Mechanisms and potential upstream therapies
    • Zhang Q, Liu T, Ng CY, et al. Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies. Cardiovasc Ther 2014;32(5):233-41
    • (2014) Cardiovasc Ther , vol.32 , Issue.5 , pp. 233-241
    • Zhang, Q.1    Liu, T.2    Ng, C.Y.3
  • 30
    • 84929899795 scopus 로고    scopus 로고
    • Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies
    • Goudis CA, Korantzopoulos P, Ntalas IV, et al. Diabetes mellitus and atrial fibrillation: Pathophysiological mechanisms and potential upstream therapies. Int J Cardiol 2015;184:617-22
    • (2015) Int J Cardiol , vol.184 , pp. 617-622
    • Goudis, C.A.1    Korantzopoulos, P.2    Ntalas, I.V.3
  • 31
    • 84869453845 scopus 로고    scopus 로고
    • Changes in left atrial volume in diabetes mellitus more than diastolic dysfunction?
    • Kadappu KK, Boyd A, Eshoo S, et al. Changes in left atrial volume in diabetes mellitus: more than diastolic dysfunction? Eur Heart J Cardiovasc Imaging 2012; 13(12):1016-23
    • (2012) Eur Heart J Cardiovasc Imaging , vol.13 , Issue.12 , pp. 1016-1023
    • Kadappu, K.K.1    Boyd, A.2    Eshoo, S.3
  • 32
    • 0017256194 scopus 로고
    • Relation between echocardiographically determined left atrial size and atrial fibrillation
    • Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976; 53(2):273-9
    • (1976) Circulation , vol.53 , Issue.2 , pp. 273-279
    • Henry, W.L.1    Morganroth, J.2    Pearlman, A.S.3
  • 33
    • 78049416583 scopus 로고    scopus 로고
    • Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter
    • Lee Y-S, Hyun DW, Jung BC, et al. Left atrial volume index as a predictor for occurrence of atrial fibrillation after ablation of typical atrial flutter. J Cardiol 2010; 56(3):348-53
    • (2010) J Cardiol , vol.56 , Issue.3 , pp. 348-353
    • Lee, Y.-S.1    Hyun, D.W.2    Jung, B.C.3
  • 34
    • 74849106152 scopus 로고    scopus 로고
    • Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart
    • Otake H, Suzuki H, Honda T, et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J 2009;50(5):627-41
    • (2009) Int Heart J , vol.50 , Issue.5 , pp. 627-641
    • Otake, H.1    Suzuki, H.2    Honda, T.3
  • 35
    • 67650094848 scopus 로고    scopus 로고
    • International expert committee report on the role of the a1c assay in the diagnosis of diabetes
    • Committee TIE. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 2009;32(7):1327-34
    • (2009) Diabetes Care , vol.32 , Issue.7 , pp. 1327-1334
    • Tie, C.1
  • 36
    • 84155171309 scopus 로고    scopus 로고
    • Type 2 diabetes glucose homeostasis and incident atrial fibrillation: The Atherosclerosis Risk in Communities study
    • Huxley RR, Alonso A, Lopez FL, et al. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart 2012;98(2):133-8
    • (2012) Heart , vol.98 , Issue.2 , pp. 133-138
    • Huxley, R.R.1    Alonso, A.2    Lopez, F.L.3
  • 37
    • 84858294504 scopus 로고    scopus 로고
    • HbA1c and atrial fibrillation: A cross-sectional study in Japan
    • Iguchi Y, Kimura K, Shibazaki K, et al. HbA1c and atrial fibrillation: a cross-sectional study in Japan. Int J Cardiol 2012;156(2):156-9
    • (2012) Int J Cardiol , vol.156 , Issue.2 , pp. 156-159
    • Iguchi, Y.1    Kimura, K.2    Shibazaki, K.3
  • 38
    • 84921726558 scopus 로고    scopus 로고
    • Impact of intensive Glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study)
    • Fatemi O, Yuriditsky E, Tsioufis C, et al. Impact of intensive Glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the action to control cardiovascular risk in diabetes study). Am J Cardiol 2014;114(8):1217-22
    • (2014) Am J Cardiol , vol.114 , Issue.8 , pp. 1217-1222
    • Fatemi, O.1    Yuriditsky, E.2    Tsioufis, C.3
  • 39
    • 34548455445 scopus 로고    scopus 로고
    • Independent predictors of stroke in patients with atrial fibrillation: A systematic review
    • Stroke Risk in Atrial Fibrillation Working Group
    • Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69(6):546-54
    • (2007) Neurology , vol.69 , Issue.6 , pp. 546-554
  • 40
    • 0028244264 scopus 로고
    • Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation Analysis of pooled data from five randomized controlled trials
    • Atrial Fibrillation Investigators
    • Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994; 154(13):1449-57
    • (1994) Arch Intern Med , vol.154 , Issue.13 , pp. 1449-1457
  • 41
    • 0033063754 scopus 로고    scopus 로고
    • Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation analysis of 2012 participants in the SPAF I- III clinical trials
    • Hart RG, Pearce LA, McBride R, et al. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation analysis of 2012 participants in the SPAF I- III clinical trials. Stroke 1999;30(6):1223-9
    • (1999) Stroke , vol.30 , Issue.6 , pp. 1223-1229
    • Hart, R.G.1    Pearce, L.A.2    McBride, R.3
  • 42
    • 25444464098 scopus 로고    scopus 로고
    • Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation the anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    • Fang MC, Singer DE, Chang Y, et al. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2005;112(12):1687-91
    • (2005) Circulation , vol.112 , Issue.12 , pp. 1687-1691
    • Fang, M.C.1    Singer, D.E.2    Chang, Y.3
  • 43
    • 0001183687 scopus 로고    scopus 로고
    • Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation
    • Stollberger C, Chnupa P, Kronik G, et al. Transesophageal echocardiography to assess embolic risk in patients with atrial fibrillation. Ann Intern Med 1998;128(8):630-8
    • (1998) Ann Intern Med , vol.128 , Issue.8 , pp. 630-638
    • Stollberger, C.1    Chnupa, P.2    Kronik, G.3
  • 44
    • 0042422040 scopus 로고    scopus 로고
    • A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham heart study
    • Wang TJ, Massaro JM, Levy D, et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham heart study. JAMA 2003; 290(8):1049-56
    • (2003) JAMA , vol.290 , Issue.8 , pp. 1049-1056
    • Wang, T.J.1    Massaro, J.M.2    Levy, D.3
  • 45
    • 0026072767 scopus 로고
    • Risk factors for stroke in patients with nonrheumatic atrial fibrillation: A case-control study
    • Moulton AW, Singer DE, Haas JS. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study. Am J Med 1991;91(2): 156-61
    • (1991) Am J Med , vol.91 , Issue.2 , pp. 156-161
    • Moulton, A.W.1    Singer, D.E.2    Haas, J.S.3
  • 46
    • 84928605580 scopus 로고    scopus 로고
    • Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: A cohort study
    • [Epub ahead of print]
    • Saliba W, Barnett-Griness O, Elias M, et al. Glycated hemoglobin and risk of first episode stroke in diabetic patients with atrial fibrillation: a cohort study. Heart Rhythm 2015. [Epub ahead of print]
    • (2015) Heart Rhythm
    • Saliba, W.1    Barnett-Griness, O.2    Elias, M.3
  • 47
    • 37149029659 scopus 로고    scopus 로고
    • Diabetes, the metabolic syndrome, and ischemic stroke epidemiology and possible mechanisms
    • Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke epidemiology and possible mechanisms. Diabetes Care 2007;30(12):3131-40
    • (2007) Diabetes Care , vol.30 , Issue.12 , pp. 3131-3140
    • Air, E.L.1    Kissela, B.M.2
  • 48
    • 33645077624 scopus 로고    scopus 로고
    • Diabetes and stroke: Part one-risk factors and pathophysiology
    • Baliga BS, Weinberger J. Diabetes and stroke: part one-risk factors and pathophysiology. Curr Cardiol Rep 2006; 8(1):23-8
    • (2006) Curr Cardiol Rep , vol.8 , Issue.1 , pp. 23-28
    • Baliga, B.S.1    Weinberger, J.2
  • 49
    • 84867841919 scopus 로고    scopus 로고
    • Stroke and thromboembolism in atrial fibrillation
    • Pisters R, Lane DA, Marin F, et al. Stroke and thromboembolism in atrial fibrillation. Circ J 2012;76(10):2289-304
    • Circ J 2012 , vol.76 , Issue.10 , pp. 2289-2304
    • Pisters, R.1    Lane, D.A.2    Marin, F.3
  • 50
    • 84875508668 scopus 로고    scopus 로고
    • Focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillationDeveloped with the special contribution of the European Heart Rhythm Association
    • Camm AJ, Lip GYH, Caterina RD, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation An update of the 2010 ESC Guidelines for the management of atrial fibrillationDeveloped with the special contribution of the European Heart Rhythm Association. Europace 2012;14(10):1385-413
    • (2012) Europace 2012 , vol.14 , Issue.10 , pp. 1385-1413
    • Camm, A.J.1    Gyh, L.2    Caterina, R.D.3
  • 51
    • 84908220640 scopus 로고    scopus 로고
    • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol 2014;64(21): e1-76
    • (2014) J Am Coll Cardiol , vol.64 , Issue.21 , pp. e1-76
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3
  • 52
    • 76749163232 scopus 로고    scopus 로고
    • Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation
    • Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010; 137(2):263-72
    • (2010) Chest , vol.137 , Issue.2 , pp. 263-272
    • Gyh, L.1    Nieuwlaat, R.2    Pisters, R.3
  • 53
    • 6444240752 scopus 로고    scopus 로고
    • Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin
    • Gage BF, van Walraven C, Pearce L, et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 2004; 110(16):2287-92
    • (2004) Circulation , vol.110 , Issue.16 , pp. 2287-2292
    • Gage, B.F.1    Van Walraven, C.2    Pearce, L.3
  • 54
    • 79551645746 scopus 로고    scopus 로고
    • Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: Nationwide cohort study
    • [[Cited 13 June 2013]
    • Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ [Internet] 2011;342: Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3031123/[[Cited 13 June 2013]
    • (2011) BMJ [Internet] , pp. 342
    • Olesen, J.B.1    Lip, G.Y.H.2    Hansen, M.L.3
  • 55
    • 33751255101 scopus 로고    scopus 로고
    • DEvelopment of a contemporary bleeding risk model for elderly warfarin recipients
    • Shireman TI, Mahnken JD, Howard PA, et al. DEvelopment of a contemporary bleeding risk model for elderly warfarin recipients. Chest 2006;130(5):1390-6
    • (2006) Chest , vol.130 , Issue.5 , pp. 1390-1396
    • Shireman, T.I.1    Mahnken, J.D.2    Howard, P.A.3
  • 56
    • 0032144231 scopus 로고    scopus 로고
    • Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
    • Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105(2):91-9
    • (1998) Am J Med , vol.105 , Issue.2 , pp. 91-99
    • Beyth, R.J.1    Quinn, L.M.2    Landefeld, C.S.3
  • 57
    • 80052094564 scopus 로고    scopus 로고
    • A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    • Fang MC, Go AS, Chang Y, et al. A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol 2011;58(4): 395-401
    • J Am Coll Cardiol 2011 , vol.58 , Issue.4 , pp. 395-401
    • Fang, M.C.1    Go, A.S.2    Chang, Y.3
  • 58
    • 77955872745 scopus 로고    scopus 로고
    • A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro heart survey
    • Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro heart survey. Chest 2010;138(5):1093-100
    • (2010) Chest , vol.138 , Issue.5 , pp. 1093-1100
    • Pisters, R.1    Lane, D.A.2    Nieuwlaat, R.3
  • 59
    • 33344461585 scopus 로고    scopus 로고
    • Clinical classification schemes for predicting hemorrhage: Results from the national registry of atrial fibrillation (NRAF)
    • Gage BF, Yan Y, Milligan PE, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 2006;151(3):713-19
    • (2006) Am Heart J , vol.151 , Issue.3 , pp. 713-719
    • Gage, B.F.1    Yan, Y.2    Milligan, P.E.3
  • 60
    • 79955439399 scopus 로고    scopus 로고
    • Bleeding risk assessment and management in atrial fibrillation patients: A position document from the european heart rhythm association endorsed by the european society of cardiology working group on thrombosis
    • Lip GYH, Andreotti F, Fauchier L, et al. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis. Europace 2011; 13(5):723-46
    • (2011) Europace , vol.13 , Issue.5 , pp. 723-746
    • Gyh, L.1    Andreotti, F.2    Fauchier, L.3
  • 61
    • 25444511088 scopus 로고    scopus 로고
    • Type 2 diabetes mellitus: A cardiovascular perspective
    • Varughese GI, Tomson J, Lip GYH. Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract 2005;59(7): 798-816
    • (2005) Int J Clin Pract , vol.59 , Issue.7 , pp. 798-816
    • Varughese, G.I.1    Tomson, J.2    Gyh, L.3
  • 62
    • 0023266532 scopus 로고
    • Effects of enalapril on mortality in severe congestive heart failure
    • Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316(23):1429-35
    • (1987) N Engl J Med , vol.316 , Issue.23 , pp. 1429-1435
  • 63
    • 77950322953 scopus 로고    scopus 로고
    • Atrial fibrillation in congestive heart failure
    • Lubitz SA, Benjamin EJ, Ellinor PT. Atrial fibrillation in congestive heart failure. Heart Fail Clin 2010;6(2):187-200
    • (2010) Heart Fail Clin , vol.6 , Issue.2 , pp. 187-200
    • Lubitz, S.A.1    Benjamin, E.J.2    Ellinor, P.T.3
  • 64
    • 84891555789 scopus 로고    scopus 로고
    • Conundrum of pathogenesis of diabetic cardiomyopathy: Role of vascular endothelial dysfunction reactive oxygen species and mitochondria
    • Joshi M, Kotha SR, Malireddy S, et al. Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria. Mol Cell Biochem 2014; 386(1-2):233-49
    • (2014) Mol Cell Biochem , vol.386 , Issue.1-2 , pp. 233-249
    • Joshi, M.1    Kotha, S.R.2    Malireddy, S.3
  • 65
    • 65949110355 scopus 로고    scopus 로고
    • Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: Results of the ADVANCE study
    • Du X, Ninomiya T, de Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 2009;30(9):1128-35
    • (2009) Eur Heart J , vol.30 , Issue.9 , pp. 1128-1135
    • Du, X.1    Ninomiya, T.2    De Galan, B.3
  • 66
    • 84862805386 scopus 로고    scopus 로고
    • Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: A review of current evidence
    • Liu T, Li G. Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: a review of current evidence. Int J Cardiol 2012;156(2):215-16
    • (2012) Int J Cardiol , vol.156 , Issue.2 , pp. 215-216
    • Liu, T.1    Li, G.2
  • 67
    • 84903946876 scopus 로고    scopus 로고
    • Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits
    • Liu T, Zhao H, Li J, et al. Rosiglitazone attenuates atrial structural remodeling and atrial fibrillation promotion in alloxan-induced diabetic rabbits. Cardiovasc Ther 2014;32(4):178-83
    • (2014) Cardiovasc Ther , vol.32 , Issue.4 , pp. 178-183
    • Liu, T.1    Zhao, H.2    Li, J.3
  • 68
    • 84858275950 scopus 로고    scopus 로고
    • Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes
    • Chao T-F, Leu H-B, Huang C-C, et al. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes. Int J Cardiol 2012;156(2):199-202
    • (2012) Int J Cardiol , vol.156 , Issue.2 , pp. 199-202
    • Chao, T.-F.1    Leu, H.-B.2    Huang, C.-C.3
  • 69
    • 80052243947 scopus 로고    scopus 로고
    • Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus
    • Gu J, Liu X, Wang X, et al. Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus. Europace 2011; 13(9):1256-61
    • (2011) Europace , vol.13 , Issue.9 , pp. 1256-1261
    • Gu, J.1    Liu, X.2    Wang, X.3
  • 70
    • 84908068320 scopus 로고    scopus 로고
    • Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: A population-based dynamic cohort and in vitro studies
    • [Cited 31 March 2015]
    • Chang S-H, Wu L-S, Chiou M-J, et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies. Cardiovasc Diabetol [Internet] 2014;13: Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC4149273/[[Cited 31 March 2015]
    • (2014) Cardiovasc Diabetol [Internet] , vol.13
    • Chang, S.-H.1    Wu, L.-S.2    Chiou, M.-J.3
  • 71
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365(11):981-92
    • (2011) N Engl J Med , vol.365 , Issue.11 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    Jjv, M.3
  • 72
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361(12):1139-51
    • (2009) N Engl J Med , vol.361 , Issue.12 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 73
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365(10):883-91
    • (2011) N Engl J Med , vol.365 , Issue.10 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 74
    • 84871511861 scopus 로고    scopus 로고
    • New oral anticoagulants for stroke prevention in atrial fibrillation: Impact of gender heart failure diabetes mellitus and paroxysmal atrial fibrillation
    • Ahmad Y, Lip GYH, Apostolakis S. New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation. Expert Rev Cardiovasc Ther 2012;10(12):1471-80
    • (2012) Expert Rev Cardiovasc Ther , vol.10 , Issue.12 , pp. 1471-1480
    • Ahmad, Y.1    Gyh, L.2    Apostolakis, S.3
  • 75
    • 84900606777 scopus 로고    scopus 로고
    • Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study
    • Crijns HJGM, Weijs B, Fairley A-M, et al. Contemporary real life cardioversion of atrial fibrillation: results from the multinational RHYTHM-AF study. Int J Cardiol 2014;172(3):588-94
    • (2014) Int J Cardiol , vol.172 , Issue.3 , pp. 588-594
    • Hjgm, C.1    Weijs, B.2    Fairley, A.-M.3
  • 76
    • 39849109823 scopus 로고    scopus 로고
    • Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation
    • Soran H, Younis N, Currie P, et al. Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation. QJM 2008;101(3):181-7
    • (2008) QJM , vol.101 , Issue.3 , pp. 181-187
    • Soran, H.1    Younis, N.2    Currie, P.3
  • 77
    • 84920367855 scopus 로고    scopus 로고
    • Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion
    • Luong C, Thompson DJS, Bennett M, et al. Right atrial volume is superior to left atrial volume for prediction of atrial fibrillation recurrence after direct current cardioversion. Can J Cardiol 2015;31(1): 29-35
    • (2015) Can J Cardiol , vol.31 , Issue.1 , pp. 29-35
    • Luong, C.1    Djs, T.2    Bennett, M.3
  • 78
    • 84906890542 scopus 로고    scopus 로고
    • Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy
    • Dąbrowski R, Opolski G, Włodarczyk P, et al. Demographic and clinical characteristics of patients with atrial fibrillation and cardioversion as planned therapeutic options in the International Registry on Cardioversion of Atrial Fibrillation RHYTHM-AF Polish substudy. Kardiol Pol 2014;72(8):700-6
    • (2014) Kardiol Pol , vol.72 , Issue.8 , pp. 700-706
    • Dąbrowski, R.1    Opolski, G.2    Włodarczyk, P.3
  • 79
    • 0035713510 scopus 로고    scopus 로고
    • Factors related to the early and late success of direct current cardioversion of chronic nonrheumatic atrial fibrillation: An echocardiographic study
    • Szulc M, Gurba H, Kuch-Wocial A, et al. Factors related to the early and late success of direct current cardioversion of chronic nonrheumatic atrial fibrillation: an echocardiographic study. Exp Clin Cardiol 2001;6(4):200-5
    • (2001) Exp Clin Cardiol , vol.6 , Issue.4 , pp. 200-205
    • Szulc, M.1    Gurba, H.2    Kuch-Wocial, A.3
  • 80
    • 33845584642 scopus 로고    scopus 로고
    • Effects of cardioversion of atrial fibrillation on endothelial function in hypertension or diabetes
    • Guazzi M, Belletti S, Lenatti L, et al. Effects of cardioversion of atrial fibrillation on endothelial function in hypertension or diabetes. Eur J Clin Invest 2007;37(1): 26-34
    • (2007) Eur J Clin Invest , vol.37 , Issue.1 , pp. 26-34
    • Guazzi, M.1    Belletti, S.2    Lenatti, L.3
  • 81
    • 84884387388 scopus 로고    scopus 로고
    • Thromboembolic complications after cardioversion of acute atrial fibrillation: The FinCV (Finnish CardioVersion) Study
    • Airaksinen KEJ, Gronberg T, Nuotio I, et al. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) Study. J Am Coll Cardiol 2013;62(13):1187-92
    • (2013) J Am Coll Cardiol , vol.62 , Issue.13 , pp. 1187-1192
    • Kej, A.1    Gronberg, T.2    Nuotio, I.3
  • 82
    • 33847139430 scopus 로고    scopus 로고
    • Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus-single center experience
    • Tang RB, Dong JZ, Liu XP, et al. Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus-single center experience. J Interv Card Electrophysiol 2006;17(1):41-6
    • (2006) J Interv Card Electrophysiol , vol.17 , Issue.1 , pp. 41-46
    • Tang, R.B.1    Dong, J.Z.2    Liu, X.P.3
  • 83
    • 78649332334 scopus 로고    scopus 로고
    • Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose
    • Chao T-F, Suenari K, Chang S-L, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol 2010;106(11): 1615-20
    • (2010) Am J Cardiol , vol.106 , Issue.11 , pp. 1615-1620
    • Chao, T.-F.1    Suenari, K.2    Chang, S.-L.3
  • 84
    • 84929906799 scopus 로고    scopus 로고
    • HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation
    • Lu Z-H, Liu N, Bai R, et al. HbA1c levels as predictors of ablation outcome in type 2 diabetes mellitus and paroxysmal atrial fibrillation. Herz 2014;1-7
    • Herz , vol.2014 , pp. 1-7
    • Lu, Z.-H.1    Liu, N.2    Bai, R.3
  • 85
    • 84876514360 scopus 로고    scopus 로고
    • Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus
    • [[Cited 26 January 2015]
    • Lin Y, Li H, Lan X, et al. Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus. ScientificWorldJournal [Internet] 2013; Available from: www.ncbi.nlm.nih.gov/pmc/articles/PMC3612491/[[Cited 26 January 2015]
    • (2013) ScientificWorldJournal [Internet]
    • Lin, Y.1    Li, H.2    Lan, X.3
  • 86
    • 84929934947 scopus 로고    scopus 로고
    • Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam
    • Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf 2014;6: 155-65
    • (2014) Drug Healthc Patient Saf , vol.6 , pp. 155-165
    • Kamuhabwa, A.R.1    Charles, E.2
  • 87
    • 65549130012 scopus 로고    scopus 로고
    • Factors associated with glycemic control after an inpatient program
    • Maruyama S, Sakura H, Kanno H, et al. Factors associated with glycemic control after an inpatient program. Metabolism 2009;58(6):843-7
    • (2009) Metabolism , vol.58 , Issue.6 , pp. 843-847
    • Maruyama, S.1    Sakura, H.2    Kanno, H.3
  • 88
    • 77957699729 scopus 로고    scopus 로고
    • Guidelines for the management of atrial fibrillation: The task force for the management of atrial fibrillation of the European society of cardiology (ESC)
    • Camm AJ, Kirchhof P, Lip GYH, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010;31(19):2369-429
    • (2010) Eur Heart J , vol.31 , Issue.19 , pp. 2369-2429
    • Camm, A.J.1    Kirchhof, P.2    Gyh, L.3
  • 89
    • 67649379280 scopus 로고    scopus 로고
    • Erythropoietic stress and anemia in diabetes mellitus
    • Singh DK, Winocour P, Farrington K. Erythropoietic stress and anemia in diabetes mellitus. Nat Rev Endocrinol 2009;5(4): 204-10
    • (2009) Nat Rev Endocrinol , vol.5 , Issue.4 , pp. 204-210
    • Singh, D.K.1    Winocour, P.2    Farrington, K.3
  • 92
    • 58149229426 scopus 로고    scopus 로고
    • Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: Results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy
    • Forleo GB, Mantica M, De Luca L, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009;20(1):22-8
    • (2009) J Cardiovasc Electrophysiol , vol.20 , Issue.1 , pp. 22-28
    • Forleo, G.B.1    Mantica, M.2    De Luca, L.3
  • 93
    • 84906882822 scopus 로고    scopus 로고
    • Global regional and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the Global Burden of Disease Study 2013
    • Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384(9945):766-81
    • (2014) Lancet , vol.384 , Issue.9945 , pp. 766-781
    • Ng, M.1    Fleming, T.2    Robinson, M.3
  • 94
    • 84878289276 scopus 로고    scopus 로고
    • Obesity is a risk factor for atrial fibrillation among fertile young women: A nationwide cohort study
    • Karasoy D, Bo Jensen T, Hansen ML, et al. Obesity is a risk factor for atrial fibrillation among fertile young women: a nationwide cohort study. Europace 2013; 15(6):781-6
    • (2013) Europace , vol.15 , Issue.6 , pp. 781-786
    • Karasoy, D.1    Bo Jensen, T.2    Hansen, M.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.